Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR vs LENALIDOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR vs LENALIDOMIDE: Safety Overview

Metric LEDIPASVIR LENALIDOMIDE
Total FAERS Reports 516 349,955
Deaths Reported 304 35,942
Death Rate 58.9% 10.3%
Hospitalizations 34 86,495
Average Patient Age 58.5 yrs 69.9 yrs
% Female Patients 29.5% 50.0%
FDA Approval Date N/A Aug 3, 2023
Manufacturer Gilead Sciences, Inc Padagis US LLC
Route ORAL ORAL
Marketing Status N/A Prescription